Scalp Psoriasis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2017-06-19
FDA Approved: TACLONEX — Supplemental Application (LEO Pharma Inc.)
The FDA approved a supplemental application for Taclonex (calcipotriene and betamethone dipropionate) from LEO Pharma Inc., under NDA 022185…